{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:23:24Z","timestamp":1792794204779,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD) is a multifactorial disorder characterized by aberrant immune activation and metabolic dysregulation. Despite significant advances in understanding immune mechanisms, the temporal dynamics of metabolic alterations during intestinal inflammation and their therapeutic implications remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To investigate metabolic reprogramming during colitis progression, we conducted time-resolved metabolomic profiling of the colon, mesenteric lymph nodes (MLNs), and serum in a dextran sulfate sodium (DSS)-induced murine colitis model at days 1, 3, 5, and 7 post-induction. Targeted and untargeted metabolomic analyses were integrated with pathological and immunological assessments. To assess therapeutic relevance, DSS-treated mice were administered either trigonelline, a metabolite identified in serum, or mycophenolic acid (MPA), a purine metabolism inhibitor, separately. Metabolomic profiling revealed a progressive activation of purine metabolism in colonic tissues and MLNs, correlating with enhanced immune-inflammatory responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Trigonelline was identified as a serum biomarker positively associated with disease severity. Therapeutic treatment with either trigonelline or MPA significantly alleviated histopathological damage, reduced inflammatory cell infiltration in both the colon and MLNs, and restored the Th17\/Treg cell balance. Mechanistic studies indicated that trigonelline and MPA individually suppress pro-inflammatory signaling pathways while promoting regulatory immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a comprehensive temporal map of metabolic reprogramming during colitis progression and identifies purine metabolism and trigonelline as novel therapeutic targets. These findings highlight the translational potential of multi-organ metabolomic approaches in elucidating disease mechanisms and guiding precision treatment strategies for IBD and related inflammatory conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1691978","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:29:36Z","timestamp":1763965776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Temporal metabolic reprogramming in DSS-induced colitis identifies purine metabolism and trigonelline as novel therapeutic targets"],"prefix":"10.3389","volume":"16","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"dmm050895","DOI":"10.1242\/dmm.050895","article-title":"Immunometabolism and mitochondria in inflammatory bowel disease: a role for therapeutic intervention?","volume":"17","author":"Adams","year":"2024","journal-title":"Dis. Model Mech."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpba.2018.06.027","article-title":"Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk","volume":"159","author":"Anwar","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2018.11.016","article-title":"Metabolic regulation of infection and inflammation","volume":"112","author":"Chauhan","year":"2018","journal-title":"Cytokine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1055914","DOI":"10.3389\/fimmu.2022.1055914","article-title":"The role of Th17 cells in inflammatory bowel disease and the research progress","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11011-017-0147-5","article-title":"Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice","volume":"33","author":"Chowdhury","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e8681","DOI":"10.7717\/peerj.8681","article-title":"Expanding the utility of the dextran sulfate sodium (DSS) mouse model to induce a clinically relevant loss of intestinal barrier function","volume":"8","author":"Cochran","year":"2020","journal-title":"PeerJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"E827-E834","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/nu13010167","article-title":"Regulation of gastrointestinal immunity by metabolites","volume":"13","author":"Gu","year":"2021","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7247238","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J. Immunol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41423-021-00833-2","article-title":"Microenvironmental influences on T cell immunity in cancer and inflammation","volume":"19","author":"Heintzman","year":"2022","journal-title":"Cell. and Mol. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41556-018-0217-x","article-title":"Metabolism as a guiding force for immunity","volume":"21","author":"Jung","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.chom.2023.05.011","article-title":"Gut bacterial metabolism contributes to host global purine homeostasis","volume":"31","author":"Kasahara","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","article-title":"Purine release, metabolism, and signaling in the inflammatory response","volume":"37","author":"Linden","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature25437","article-title":"Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism","volume":"554","author":"Mao","year":"2018","journal-title":"Nature"},{"key":"B19","volume-title":"Inflammatory bowel disease, StatPearls, StatPearls publishing copyright \u00a9 2025","author":"McDowell","year":"2025"},{"key":"B20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s42255-024-00997-x","article-title":"Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia","volume":"6","author":"Membrez","year":"2024","journal-title":"Nat. Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/nprot.2007.279","article-title":"An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression","volume":"2","author":"Neufert","year":"2007","journal-title":"Nat. Protoc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"P\u00e5lsson-McDermott","year":"2020","journal-title":"Cell Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fimmu.2012.00107","article-title":"Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer","volume":"3","author":"Rubin","year":"2012","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","article-title":"Immune regulation through tryptophan metabolism","volume":"55","author":"Seo","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/apha.12430","article-title":"The role of serotonin and its receptors in activation of immune responses and inflammation","volume":"213","author":"Shajib","year":"2015","journal-title":"Acta Physiol. (Oxf)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41420-025-02403-1","article-title":"Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives","volume":"11","author":"Shi","year":"2025","journal-title":"Cell Death Discov."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1021\/acs.jproteome.3c00860","article-title":"Integrated metabolomics and proteomics of symptomatic and early presymptomatic states of colitis","volume":"23","author":"Shimshoni","year":"2024","journal-title":"J. Proteome Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","article-title":"Tryptophan metabolism in inflammaging: from biomarker to therapeutic target","volume":"10","author":"Sorgdrager","year":"2019","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","article-title":"Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution","volume":"6","author":"Sukka","year":"2024","journal-title":"Nat. Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.3390\/ijms24065742","article-title":"The tryptophan and kynurenine pathway involved in the development of immune-related diseases","volume":"24","author":"Tsuji","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41422-025-01074-y","article-title":"Metabolite is a part of immune-regulating circuit","volume":"35","author":"Wang","year":"2025","journal-title":"Cell Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molcel.2023.12.015","article-title":"A GAPDH serotonylation system couples CD8(+) T cell glycolytic metabolism to antitumor immunity","volume":"84","author":"Wang","year":"2024","journal-title":"Mol. Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1021\/np4006772","article-title":"Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis","volume":"76","author":"Xiao","year":"2013","journal-title":"J. Nat. Prod."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12943-024-02164-y","article-title":"Molecular mechanisms and therapeutic significance of tryptophan metabolism and signaling in cancer","volume":"23","author":"Yan","year":"2024","journal-title":"Mol. Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/ibd\/izab024","article-title":"Targeting immune cell metabolism in the treatment of inflammatory bowel disease","volume":"27","author":"Zaiatz Bittencourt","year":"2021","journal-title":"Inflamm. Bowel Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1691978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:29:37Z","timestamp":1763965777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1691978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":36,"alternative-id":["10.3389\/fphar.2025.1691978"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1691978","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"article-number":"1691978"}}